Dupont Capital Management Corp Cure Vac N.V. Transaction History

Dupont Capital Management Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 30, 2021	SELL	$56.91 - $127.53 $3,073 - $6,886	-54 Closed	0 $0
Q1 2021 Apr 29, 2021	SELL	$79.79 - $126.29 $283,254 - $448,329	-3,550 Reduced 98.5%	54 $5,000
Q4 2020 Jan 28, 2021	SELL	$46.76 - $136.27 $71,589 - $208,629	-1,531 Reduced 29.81%	3,604 $292,000
Q3 2020 Oct 29, 2020	BUY	$43.8 - $77.2 $224,912 - $396,422	5,135 New	5,135 $239,000

12.3M

164K

117K

Ticker CVAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,467,008
Market Cap $877M
Description
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

Stay updated on Dupont Capital Management Corp with notifications on news.